Treatment of retinitis pigmentosa with human umbilical cord cells
US7413734B2 · kind B2 · utility
175Cited by
59References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2004 |
| Grant date | Aug 19, 2008 |
| Priority date | — |
| Expiry date | Jun 25, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cells derived from postpartum umbilicus and placenta are disclosed. Pharmaceutical compositions, devices and methods for the regeneration or repair of ocular tissue using the postpartum-derived cells are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.